|
05 Jan 2007 |
Medivir Files Clinical Trial Application To Start Phase I With MIV-701
|
|
05 Jan 2007 |
Roche and Synosis Therapeutics Announce Partnership to Explore Potential of Five Compounds Targeting the Central Nervous System
|
|
05 Jan 2007 |
Pharmacopeia Enters into a Research and License Agreement with Wyeth to Develop Novel JAK3 Inhibitors for the Treatment of Immunological and Inflammatory Diseases
|
|
05 Jan 2007 |
Alkermes and Indevus Announce Joint Collaboration to Develop Inhaled Formulation of Trospium Chloride for the Treatment of COPD
|
|
05 Jan 2007 |
Oscient Pharmaceuticals and Menarini Group Enter into European Commercialization Agreement for FACTIVE Tablets
|
|
05 Jan 2007 |
Sunesis Out-Licenses LFA-1 Program to SARcode Corporation
|
|
05 Jan 2007 |
AVEO acquires Clinical Stage Anti-Cancer Compound from Kirin
|
|
05 Jan 2007 |
Sound Pharmaceuticals Announces the Successful Completion of its Phase I Clinical Trial for SPI-1005
|
|
05 Jan 2007 |
BiPar Sciences Begins Enrollment in Phase 1b Study of BSI-201
|
|
05 Jan 2007 |
Neosil Announces Positive Phase 2 Data for NEOSH101, an Investigational Treatment for Androgenetic Alopecia
|
|
05 Jan 2007 |
Enzon Pharmaceuticals Files Investigational New Drug Application for Novel HIF-1alpha Antagonist in Cancer
|
|
05 Jan 2007 |
BioMarin Initiates Phase 2 Clinical Study of 6R-BH4 in Peripheral Arterial Disease
|
|
04 Jan 2007 |
Cytokinetics and Amgen Announce Strategic Alliance in Heart Failure
|
|
04 Jan 2007 |
D-Pharm announces positive Phase IIb trial results for DP-b99 in acute stroke patients
|
|
04 Jan 2007 |
Theravance Initiates Phase 2 Clinical Program with Investigational Heterodimer Antibiotic
|
|
04 Jan 2007 |
Catalyst Pharmaceutical Partners Provides an Update on Its Clinical Development Plans for CPP-109
|
|
04 Jan 2007 |
Aerovance Announces Positive Top-Line Results from Phase 2a Trial of Inhaled AEROVANT(TM) in Asthma Patients
|
|
04 Jan 2007 |
DURECT Starts Phase II Dosing for TRANSDUR(TM)-Bupivacaine (DUR-843)
|
|
04 Jan 2007 |
Poniard Pharmaceuticals Receives Special Protocol Assessment for Pivotal Phase 3 Trial of Picoplatin for Small Cell Lung Cancer
|
|
04 Jan 2007 |
Genaera Corporation Terminates Evizon(TM) Clinical Program And Restructures
|
|
03 Jan 2007 |
Exelixis Signs Co-Development Agreement With Genentech for Small Molecule Oncology Compound
|
|
03 Jan 2007 |
Phase II clinical trial of Biomira's PX-12 in patients with advanced pancreatic cancer now open for patient enrollment
|
|
03 Jan 2007 |
Daiichi Sankyo, Inc. Announces Filing Of Supplemental New Drug Application For WelChol In The Treatment Of Type 2 Diabetes Mellitus
|
